IL135825A0 - Use of mirtazapine for treating sleep apneas - Google Patents

Use of mirtazapine for treating sleep apneas

Info

Publication number
IL135825A0
IL135825A0 IL13582598A IL13582598A IL135825A0 IL 135825 A0 IL135825 A0 IL 135825A0 IL 13582598 A IL13582598 A IL 13582598A IL 13582598 A IL13582598 A IL 13582598A IL 135825 A0 IL135825 A0 IL 135825A0
Authority
IL
Israel
Prior art keywords
mirtazapine
treating sleep
sleep apneas
apneas
treating
Prior art date
Application number
IL13582598A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL135825A0 publication Critical patent/IL135825A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL13582598A 1997-11-14 1998-11-13 Use of mirtazapine for treating sleep apneas IL135825A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203548 1997-11-14
PCT/EP1998/007330 WO1999025356A1 (en) 1997-11-14 1998-11-13 Use of mirtazapine for treating sleep apneas

Publications (1)

Publication Number Publication Date
IL135825A0 true IL135825A0 (en) 2001-05-20

Family

ID=8228923

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13582598A IL135825A0 (en) 1997-11-14 1998-11-13 Use of mirtazapine for treating sleep apneas
IL135825A IL135825A (en) 1997-11-14 2000-04-25 Production of a medicinal product that includes myrtzepine for the treatment of sleep apnea

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL135825A IL135825A (en) 1997-11-14 2000-04-25 Production of a medicinal product that includes myrtzepine for the treatment of sleep apnea

Country Status (21)

Country Link
US (1) US6303595B1 (xx)
EP (1) EP1030667B1 (xx)
JP (1) JP2001522891A (xx)
KR (1) KR20010032009A (xx)
CN (1) CN1154495C (xx)
AT (1) ATE289816T1 (xx)
AU (1) AU737590B2 (xx)
BR (1) BR9815098A (xx)
CA (1) CA2309744A1 (xx)
CZ (1) CZ296282B6 (xx)
DE (1) DE69829202T2 (xx)
DK (1) DK1030667T3 (xx)
ES (1) ES2238781T3 (xx)
HK (1) HK1029932A1 (xx)
HU (1) HUP0100080A3 (xx)
IL (2) IL135825A0 (xx)
NO (1) NO20002218L (xx)
PL (1) PL192272B1 (xx)
PT (1) PT1030667E (xx)
TR (1) TR200001293T2 (xx)
WO (1) WO1999025356A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331536B1 (en) 1998-02-27 2001-12-18 The Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
PL206073B1 (pl) * 2000-02-11 2010-06-30 Organon Nv Zastosowanie mirtazapiny do wytwarzania leku
US20020183306A1 (en) * 2001-05-30 2002-12-05 Pfizer Inc. Combination treatment for sleep disorders including sleep apnea
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
EP1667972B1 (en) 2003-09-10 2013-06-19 Brentwood Equities Ltd. Diastereomers of 4-aryloxy-3-hydroxypiperidines
WO2006023703A2 (en) * 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders
WO2006055854A2 (en) * 2004-11-17 2006-05-26 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtazapine treatment
KR20070087678A (ko) * 2004-12-20 2007-08-28 컬리지움 파마슈티칼, 인코포레이티드 수면 장애용 약제 조성물
MX2009010967A (es) 2007-04-11 2009-12-15 Organon Nv Un metodo para la preparacion de mirtazapina.
WO2008157094A1 (en) * 2007-06-13 2008-12-24 Cypress Bioscience, Inc. Improving the tolerability of mirtazapine and a second active by using them in combination
WO2013188806A1 (en) * 2012-06-14 2013-12-19 The Regents Of The University Of Michigan Sleep apnea treatment
DK3261645T3 (da) 2015-02-27 2021-06-07 Dechra Ltd Stimulering af appetit, håndtering af vægttab og behandling af anoreksi hos hunde og katte

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
EP0517984A1 (en) 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines
DE69636393T2 (de) * 1995-10-24 2006-12-07 Grünenthal GmbH Montirelin zur verhinderung der schlafapnoe
SE9504537D0 (sv) * 1995-12-19 1995-12-19 Jan Hedner Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent

Also Published As

Publication number Publication date
PT1030667E (pt) 2005-06-30
BR9815098A (pt) 2000-10-10
ES2238781T3 (es) 2005-09-01
JP2001522891A (ja) 2001-11-20
EP1030667A1 (en) 2000-08-30
HUP0100080A3 (en) 2002-05-28
CZ20001751A3 (cs) 2000-10-11
PL340467A1 (en) 2001-02-12
DE69829202T2 (de) 2005-07-21
HK1029932A1 (en) 2001-04-20
CN1278731A (zh) 2001-01-03
DE69829202D1 (de) 2005-04-07
EP1030667B1 (en) 2005-03-02
HUP0100080A2 (hu) 2001-08-28
CZ296282B6 (cs) 2006-02-15
US6303595B1 (en) 2001-10-16
WO1999025356A1 (en) 1999-05-27
CA2309744A1 (en) 1999-05-27
NO20002218L (no) 2000-05-12
PL192272B1 (pl) 2006-09-29
KR20010032009A (ko) 2001-04-16
AU737590B2 (en) 2001-08-23
AU1754899A (en) 1999-06-07
CN1154495C (zh) 2004-06-23
DK1030667T3 (da) 2005-06-20
ATE289816T1 (de) 2005-03-15
TR200001293T2 (tr) 2002-09-23
IL135825A (en) 2006-12-31
NO20002218D0 (no) 2000-04-28

Similar Documents

Publication Publication Date Title
IL135825A0 (en) Use of mirtazapine for treating sleep apneas
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
HK1049671A1 (en) Substituted indoles.
NZ335981A (en) Ketobenzamides as calpain inhibitors
MY126527A (en) Novel dihydropyrimidines
MXPA03011985A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
ATE326209T1 (de) Verminderung des haarwuchses
ID28441A (id) Terapi untuk memperbaiki kesadaran
HK1048308A1 (en) Novel compounds.
EP1578760A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING TUMORS
GB0018951D0 (en) Novel compounds
AP2001002274A0 (en) Rescorcinol derivatives.
MXPA02012911A (es) Compuestos de rutenio (ii) para el uso en terapia del cancer.
GB0027705D0 (en) Novel compounds
IL131478A0 (en) Methods for treatment of scar tissue
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
ZA9711468B (en) New use of comt inhibitors
ZA983231B (en) Substituted benzyloxyimino compounds.
MXPA03001644A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
FI965171A (fi) Oksatsofosforiinien, esimerkiksi ifosfamidin, enantiomeerien käyttö kasvainten hoidossa sivuvaikutuksien vähentämiseksi
DE60102481D1 (en) Purinriboside als antiarrhythmika
PL377056A1 (pl) Nowe związki przeciwnowotworowe
GB2392617A (en) Surface Treatment of SARS-Infected Lungs
TR199801800T2 (xx) Uykusuzluk tedavisi.
UA32150A (uk) Спосіб лікування виразкової хвороби гастродуоденальної локалізації

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed